Thomas Waldmann
MD
Chief, Lymphoid Malignancies Branch (Historical)
👥Biography 个人简介
Thomas Waldmann (deceased 2021) led the NCI Lymphoid Malignancies Branch for decades and contributed to IL-2 receptor biology and IL-15 as a cancer immunotherapy cytokine. He championed IL-15 superagonists as agents for NK and T cell activation in tumors. His work laid the foundation for modern cytokine-based cancer immunotherapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Thomas Waldmann 的研究动态
Follow Thomas Waldmann's research updates
留下邮箱，当我们发布与 Thomas Waldmann（National Cancer Institute (Historical)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment